Nymox Pharmaceutical Corporation NYMX Securities Lawsuit

Company:	Nymox Pharmaceutical Corporation
Ticker Symbol:	NYMX
Class Period:	Jan-13-11 to Nov-2-14
Date Filed:	Dec-2-14
Lead Plaintiff Deadline:	Jan-31-15
Court:	District of New Jersey
Allegations:

Los Angeles, CA: A securities class action lawsuit was filed in the United States District Court for the District of New Jersey against Nymox Pharmaceutical Corporation (NASDAQ: NYMX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is January 31, 2011 through November 2, 2014.

Plaintiff seeks to recover damages on behalf of all Nymox Pharmaceutical Corporation shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Monday, January 26, 2015 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.



If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.

Nymox Pharmaceutical Corporation NYMX Securities Fraud Legal Help

If you have suffered from financial losses, you may qualify for damages or remedies that may be awarded in a possible Nymox Pharmaceutical Corporation securities class action lawsuit. Please click the link below to submit your complaint for a free evaluation.